Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation

Akikazu Kawase; Yuichi Saito

doi:10.21037/jtd-22-100

Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation

Akikazu Kawase
, Yuichi Saito

School of Medicine

Hamamatsu University School of Medicine

Research output: Contribution to journal › Review article › peer-review

Original language	English
Pages (from-to)	599-601
Number of pages	3
Journal	Journal of Thoracic Disease
Volume	14
Issue number	3
DOIs	https://doi.org/10.21037/jtd-22-100
State	Published - Mar 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.21037/jtd-22-100

Cite this

@article{d851a4d7c7794a7a9eb5dd5a757f86be,

title = "Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation",

author = "Akikazu Kawase and Yuichi Saito",

year = "2022",

month = mar,

doi = "10.21037/jtd-22-100",

language = "英語",

volume = "14",

pages = "599--601",

journal = "Journal of Thoracic Disease",

issn = "2072-1439",

publisher = "AME Publishing Company",

number = "3",

}

TY - JOUR

T1 - Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation

AU - Kawase, Akikazu

AU - Saito, Yuichi

PY - 2022/3

Y1 - 2022/3

UR - https://www.scopus.com/pages/publications/85127417062

U2 - 10.21037/jtd-22-100

DO - 10.21037/jtd-22-100

M3 - 総説

AN - SCOPUS:85127417062

SN - 2072-1439

VL - 14

SP - 599

EP - 601

JO - Journal of Thoracic Disease

JF - Journal of Thoracic Disease

IS - 3

ER -

Potential treatment strategy for the rare osimertinib resistant EGFR L718Q mutation

UN SDGs

Access to Document

Other files and links

Cite this